|
2222
|
10058-F4
|
c-Myc inhibitor inducing cell-cycle arrest at G0/G1 phase |
€80.00
|
|
1571
|
AG 7088
|
HRV3C protease inhibitor |
€60.00
|
|
2122
|
AGI 5198
|
Inhibitor of R132 mutant isocitrate dehydrogenase 1 (IDH1) |
€60.00
|
|
2274
|
AGI 6780
|
Potent and selective inhibitor of the tumor-associated mutant IDH2 (R140Q) |
€90.00
|
|
3159
|
Ambroxol hydrochloride
|
Expectorant and mucokinetic compound |
Recently added
|
€50.00
|
|
1738
|
AMD 3100
|
CXCR4 antagonist |
€85.00
|
|
2679
|
AR7
|
RARα antagonist that stimulates chaperone-mediated autophagy |
€90.00
|
|
3013
|
Aranidipine
|
Ca2+ channel antagonist |
€110.00
|
|
3140
|
Arbidol hydrochloride
|
Broad-spectrum antiviral agent |
€60.00
|
|
1317
|
Ascorbyl dodecanoate, L-
|
Vitamin C ester; Antioxidant |
€95.00
|
|
1316
|
Ascorbyl octanoate, L-
|
Vitamin C ester; Antioxidant |
€95.00
|
|
2099
|
Avridine
|
Lipoidal amine; interferon-inducing and adjuvant properties |
€80.00
|
|
3160
|
Azelnidipine
|
Calcium channel blocker |
€70.00
|
|
2042
|
Azithromycin
|
Macrolide antibiotic; Binds the 50S ribosomal subunit |
€50.00
|
|
2567
|
Azoramide
|
Modulator of the unfolded protein response (UPR) with antidiabetic activity |
€65.00
|